BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2003
View Archived Issues
Use of rhBMP-2 in lumbar arthrodesis
Read More
Four series of tyrosine kinase inhibitors identified at Ariad
Read More
Novel antibacterial DNA polymerase III inhibitors prepared and tested at Bayer
Read More
New antibacterial agents with PPAT-inhibitory activity discovered at Bayer
Read More
Bayer identifies novel thyroid hormone-like agents with utility in arteriosclerosis
Read More
Pfizer claims MTP/apo B secretion inhibitors for use in obesity and related disorders
Read More
Elan and Pharmacia team identifies novel beta-secretase inhibitors
Read More
OSI to acquire Cell Pathways
Read More
MedImmune responds to FluMist complete response letter
Read More
Pharmacopeia and AstraZeneca extend research collaboration
Read More
Milestone achieved in Pharmacopeia and Berlex collaboration
Read More
Johnson & Johnson to acquire Scios
Read More
Milnacipran improves pain in phase II FMS study
Read More
BioMarin presents overview of recent highlights
Read More
Transgene announces encouraging results from phase I oncology trials
Read More
Preclinical profile of HIV-specific CCR5 inhibitor presented in Boston
Read More
Favorable anti-HIV interactions for combination of CCR5 inhibitor and other antiretrovirals
Read More
Excellent activity reported for TMC-114 against protease inhibitor-resistant HIV
Read More
Anti-HIV effects of Racivir + d4T + efavirenz sustained after cessation of treatment in humans
Read More
AstraZeneca completes MRP in E.U. for Symbicort Turbuhaler in COPD
Read More
FDA approves Zoloft for social anxiety disorder
Read More
AstraZeneca submits MAA for Iressa for advanced NSCLC
Read More
SuperGen submits second module of rolling NDA for Orathecin
Read More